Alpha Lipoic Acid
CAS number： 1077-28-7
Molecular formula： C8H14O2S2
molecular weight： 206.32
Chemical structure：
Producers shown on SFDA
(Record date:31/08/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
Suzhou Fushilai Pharmaceutical Co., Ltd. | GMP, DMF | Valid till September 2020 |
Jiangsu Tohope Pharmaceutical Co., Ltd. | GMP | Valid till July 2023 |
Shandong Qidu Pharmaceutical Co., Ltd. | GMP | Valid till May 2023 |
Yabao Pharmaceutical Group Co., Ltd. | GMP | Valid till March 2022 |
Shanghai Shyndec Pharmaceutical Co., Ltd. | GMP | Valid till January 2019 |
Qingdao Jinfeng Pharmaceutical Co., Ltd. | GMP | Valid till May 2018 |
Dandong Yichuang Pharmaceutical Co., Ltd. | GMP | Valid till June 2020 |
Producers shown on EP
Not showing any
Producer:Suzhou Fushilai Pharmaceutical Co., Ltd., formerly known as Changshu Fujshilai Pharmaceutical And Chemical Co., Ltd., has gradually expanded from an area of only more than 10 mu in the early stage of plant construction to more than 100 mu. The company implements complete quality management, organizes production according to GMP requirements, and has passed GMP certification of pharmaceutical raw materials and on-site inspection by FDA.
The company has become one of the major professional manufacturers in China specializing in the production of lipoic acid series products, carnosine series products and phosphatidylcholine. The products are mainly exported, and have been exported to Europe, America, Southeast Asia and other foreign markets. It has established long-term supply and marketing cooperation with relevant foreign merchants.
Producer:Jiangsu Tohope Pharmaceutical Co., Ltd. is wholly-owned subsidiaries of Jiangsu Wanxing Venture Capital Co., Ltd. and are national high-tech enterprises integrating R & D, production and sales of pharmaceutical preparations, APIs and health food.
The company covers a total area of 210 mu (including 60 mu of new preparation factory), with a construction area of 26000 m2. It has shady trees, lawns and beautiful environment, presenting a strong atmosphere of garden factory. There are more than 300 employees, including more than 80 professional and technical personnel.
It passed ISO9001 quality management system certification in 2001, ERP information management in 2002, ISO14001 international environmental protection system certification and GB / T28001 (OHSAS18001) occupational health and safety management system certification in 2005, drug GMP certification in the same year and health food GMP certification in 2006.
Staff size:100-199 persons
Registered capital:RMB 120 million
Producer:Shandong Qidu Pharmaceutical Co., Ltd. is located in Linzi District, Zibo City, the former capital of the state of Qi, a famous historical and cultural city. There are more than 3800 employees, covering an area of more than 600 mu and a total asset of nearly 3 billion yuan.
Qidu Pharmaceutical Co., Ltd. is a comprehensive research-oriented pharmaceutical production enterprise focusing on injections with oral preparations and APIs. Its products mainly involve basic infusion, intravenous nutrition, plasma substitutes, anti infection, anti-tumor, cardio cerebrovascular, endocrine, pharmaceutical packaging materials and medical consumables, and has more than 170 drug production approval numbers.
The company has passed ISO9001 international quality management system certification, ISO14001 international environmental management system certification and national intellectual property management system certification.
Staff size:3000-3999 persons
Registered capital:RMB 90 million
Producer:Yabao Pharmaceutical Group Co., Ltd. is a group company with a history of more than 40 years. It was listed on the Shanghai Stock Exchange in 2002. The company integrates the R & D, production, sales, logistics and planting of traditional Chinese medicine of drugs and great health products. It has 23 subsidiaries and nearly 6000 employees.
The company has 9 production bases, 4 research bases and 4 large and medium-sized medicinal material planting bases. Among them, 6 API production lines, 2 preparation production lines and 1 plastic bottle production line have passed the certification of developed countries such as the United States, Germany and Japan.
Registered capital:RMB 770 million
On June 16, 2004, Hyundai pharmaceutical A shares were successfully issued and listed. At present, all products and dosage forms of the company have passed the GMP certification of the State Food and drug administration.
Staff size:About 15000 persons
Registered capital:RMB 1 billion 27 million
Producer:Qingdao Jinfeng Pharmaceutical Co., Ltd., founded in 1979, is a pharmaceutical enterprise jointly established with Taiwan businessmen.The business scope of the company includes the production of small volume injections (including antitumor drugs), large volume injections, etc.
Producer:Dandong Yichuang Pharmaceutical Co., Ltd. is the former Dandong pharmaceutical factory. The former Dandong Pharmaceutical Factory was founded in 1954 and is a large state-owned enterprise.
The new plant is located in the Binhai west area of Donggang Economic Development Zone, covering an area of 131 mu with a total investment of nearly 240 million yuan. As of June 2015, it has completed the new national GMP certification of small volume injection, solid oral preparation and synthetic API workshop and obtained the certificate. The company's main product dosage forms officially reached production in 2015. The new plant has formed a production capacity of 240 tons of chemical APIs, 3 billion tablets, 50 million freeze-dried powder injections and 50 million water injections.
Staff size:200-299 persons
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE